Commonwealth Informatics Launches Big Data Offering
Integrated technology platform uses temporal pattern discovery and longitudinal healthcare data to help medical safety teams detect and refine safety signals
Waltham, MA - Commonwealth Informatics, a leading provider of innovative cloud-based products and services for medical product safety and public health surveillance, today announced the general availability of CVW Longitudinal, the first module of the Commonwealth Vigilance Workbench (CVW). CVW is an integrated technology platform designed to help pharmaceutical and biotechnology companies manage a compliant signal management process incorporating analytical evidence for safety from multiple internal and external sources of data.
Recent research efforts by several multi-stakeholder public-private partnerships have demonstrated the value of enhancing safety surveillance systems with analysis of longitudinal healthcare data resources. CVW Longitudinal delivers the statistical methods, insightful graphical displays, and data interfaces needed to apply this research to signal detection and signal refinement for drug and vaccine safety. Building on methods research carried out by the Uppsala Monitoring Centre on “temporal pattern discovery in longitudinal data”, CVW Longitudinal provides the new methods as a packaged software service with the data handling, documentation, support, and security needed for production operations within the regulated pharmaceutical industry. CVW Longitudinal can be used with a wide range of healthcare data sources such as electronic medical records and insurance claims. It provides out-of-the-box analytics for multiple electronic medical record and health insurance claims databases and is cloud-based with no IT infrastructure required.
“The Commonwealth Vigilance Workbench is designed to help safety teams answer complex questions rapidly and accurately. Pharmaceutical and biotechnology companies and government regulatory agencies are looking for ways to efficiently incorporate healthcare data sources into safety signal management. CVW Longitudinal combines innovative signal detection methods with a streamlined user interface allowing teams to rapidly access these rich data sources to more effectively detect, refine and validate potential safety signals that may impact patients,” said Geoff Gordon, Commonwealth President and Founder.
Experience with using CVW Longitudinal was described in two poster presented at the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE). A team led by Manfred Hauben at Pfizer presented a poster titled: "Signal Detection Using Temporal Pattern Discovery (TPD) in Electronic Health Records (EHRs) - Lessons from Statins and Rhabdomyolysis".
About Commonwealth Informatics
Commonwealth Informatics is a technology and services company with industry expertise in medical product safety and public health surveillance. Pharmaceutical and biotechnology companies, government agencies, and healthcare providers use Commonwealth’s products and services to assemble relevant data and answer complex clinical and safety analysis questions quickly and accurately.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
